Trials / Unknown
UnknownNCT02836743
Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study
Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic REM Sleep Behavior Disorder: a Pilot Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate effect of slow-release melatonin (Circadin) on REM sleep behavior disorder.
Detailed description
Investigators planned to administer low (2mg) and high (6mg) dose slow-release melatonin and the placebo for 4 weeks and evaluate Clinical Global Impression scale, RBD questionnaire, PSQI, Epworth sleepiness scale, and quality of life questionnaire (SF-36v2) before and after the treatment along with possible side effects and drug compliance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Circadin | Slow-release melatonin |
| DRUG | Placebo |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2016-07-19
- Last updated
- 2017-04-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02836743. Inclusion in this directory is not an endorsement.